Memorial Hospital Research Laboratories

The Luis Diaz Jr. Lab

Research

Dr. Luis Alberto Diaz, Jr.
Luis Diaz Jr., MD
Head of the Division of Solid Tumor Oncology; Grayer Family Chair

Our team is focused on developing novel tools and approaches for the diagnosis and treatment of cancer using genomics as a guide.

Lab Members

Featured News

Rectal Cancer Disappears After Experimental Use of Immunotherapy
Rectal Cancer Disappears After Experimental Use of Immunotherapy
Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.

Publications Highlights

PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer
Cercek A, Lumish M, Sinopoli J, Weiss J,..,Diaz LA Jr.. N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5. PMID: 35660797, PMCID: PMC9492301.

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le DT, Uram JN, Wang H,…,Diaz LA Jr.. N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30. PMID: 26028255; PMCID: PMC4481136.

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M, Penel N, Hansen AR, Piha-Paul SA, Doi T, Gao B, Chung HC, Lopez-Martin J, Bang YJ, Frommer RS, Shah M, Ghori R, Joe AK, Pruitt SK, Diaz LA Jr.

Cancer genome landscapes.
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW.Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.

Immunotherapy in colorectal cancer: rationale, challenges and potential.
Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA Jr.

View All Publications

People

Dr. Luis Alberto Diaz, Jr.

Luis Diaz Jr., MD

Head of the Division of Solid Tumor Oncology; Grayer Family Chair

  • Our team is focused on developing novel tools and approaches for the diagnosis and treatment of cancer using genomics as a guide.
  • MD, University of Michigan
[email protected]
Email Address
646-888-4641
Office Phone
View physician profile
Physician profile

Members

Steven Maron
Assistant Attending
Somer Abdelfattah
Sr. Research Technician
Guillermo Argilés
Sr. Research Scientist
Oliver Artz
Bioinformatics software engineer-I
Andrea Cercek
Associate Attending
Michael Foote
Assistant Attending
Justin Haseltine
Assistant Attending
Rachel Hughes Rodriguez
Fellow
Paul Johannet
Assistant Attending
Nathalie Membreno
Research Technician
David Mieles
Research Technician
Miteshkumar Patel
Research Laboratory Manager
Violaine Randrian
Visiting Investigator
Karthik Rangavajhula
Benoît Camelli-Rousseau
Benoît Rousseau
Assistant Attending
Georgios Vlachos
Gradaute Research Assistant
Callahan Wilde
Research Project Associate
Joana Vidal Barrull
Joana Vidal Barrull
Visiting Investigator
Erika Gedvilaite, MS
Erika Gedvilaite
Senior Laboratory Technician
Drew Gerber
Research Technician
Michelle Lamendola-Essel
Michelle Lamendola-Essel
Project Portfolio Manager, Sr.
Sonya Li
Sonya Li
Senior Staff Scientist
Lingqi Luo
Bioinformatics Engineer II
Shrey Patel
Research Technician
Caitlin Stewart
Research Scientist
Jonathan C. M. Wan
Visiting Investigator & MD Candidate

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Luis Diaz Jr. discloses the following relationships and financial interests:

  • Absci Corporation
    Equity; Professional Services and Activities
  • ChromaCode
    Equity
  • Delfi Diagnostics, Inc.
    Equity; Professional Services and Activities (Uncompensated)
  • Epitope
    Equity; Fiduciary Role / Position
  • Function Health, Inc.
    Equity; Professional Services and Activities (Uncompensated)
  • GlaxoSmithKline
    Professional Services and Activities
  • Grove Biopharma, Inc.
    Equity; Professional Services and Activities (Uncompensated)
  • Innovatus Capital Partners, LLC
    Professional Services and Activities
  • Johns Hopkins University School of Medicine
    Intellectual Property Rights
  • Neophore
    Equity; Professional Services and Activities (Uncompensated)
  • Quest Diagnostics
    Equity; Fiduciary Role / Position
  • Seer Biosciences
    Equity; Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures